Trial Profile
A multicenter, eight-week treatment, single step titration, open-label study assessing the percentage of subjects achieving low density lipoprotein cholesterol target with atorvastatin starting doses of 10 mg, 20 mg, 40 mg, and 80 mg (Latin American atorvastatin ATGOAL study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms LA-ATGOAL
- Sponsors Pfizer
- 14 Apr 2008 New trial record.